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Abstract: Produced by several species of Aspergillus, Aflatoxin B1 (AFB1) is a carcinogenic mycotoxin
contaminating many crops worldwide. The utilization of fungicides is currently one of the most
common methods; nevertheless, their use is not environmentally or economically sound. Thus, the
use of natural compounds able to block aflatoxinogenesis could represent an alternative strategy to
limit food and feed contamination. For instance, eugenol, a 4-allyl-2-methoxyphenol present in many
essential oils, has been identified as an anti-aflatoxin molecule. However, its precise mechanism of
action has yet to be clarified. The production of AFB1 is associated with the expression of a 70 kB
cluster, and not less than 21 enzymatic reactions are necessary for its production. Based on former
empirical data, a molecular tool composed of 60 genes targeting 27 genes of aflatoxin B1 cluster and
33 genes encoding the main regulatory factors potentially involved in its production, was developed.
We showed that AFB1 inhibition in Aspergillus flavus following eugenol addition at 0.5 mM in a
Malt Extract Agar (MEA) medium resulted in a complete inhibition of the expression of all but one
gene of the AFB1 biosynthesis cluster. This transcriptomic effect followed a down-regulation of the
complex composed by the two internal regulatory factors, AflR and AflS. This phenomenon was
also influenced by an over-expression of veA and mtfA, two genes that are directly linked to AFB1
cluster regulation.
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1. Introduction
Aflatoxin B1 (AFB1) is a mycotoxin produced by many fungal species belonging to the Flavi section
of the Aspergillus genus, A. flavus being the most preoccupying species [1]. AFB1 is the most potent
naturally occurring carcinogen [2], responsible for hepatocarcinoma; it is also an immunosuppressive
agent and has been linked to growth impairment in children [3,4].
AFB1 is problematic in countries with tropical and sub-tropical climates where temperature and
humidity conditions are optimal for fungal growth and toxin production [5]. However, this danger has
spread beyond its predicted geographical borders and has reached countries previously considered as
safe. In fact, in recent years, several surveys demonstrated the contamination of European crops by this
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toxin [6,7]. Fungal infection can occur at a pre- or post-harvest stage of cereal production, especially
corn, but also oilseeds, nuts, spices and dried fruit [8].
Many strategies have been developed to reduce AFB1 contamination, either by preventing the
fungal development or by blocking the toxin’s production after infection [9]. Natural extracts are
considered as a possible alternative antimicrobial agent [10]. Indeed, organic and aqueous extracts
from plants and spices, as well as essential oils, have demonstrated fungicidal and/or anti-toxinogenic
properties [11–13]. For example, eugenol (4-allyl-2-methoxyphenol), the active compound of many
anti-toxinogenic essential oils [14,15], blocks AFB1 production in aflatoxigenic fungi [16,17]. However,
little is known about the molecular mechanism of this inhibition and the fungal pathways affected by
eugenol remain to be determined.
AFB1’s biosynthetic pathway is well characterized and consists in A. flavus, of a cluster of
27 genes whose expression is governed by two internal regulators (AflR and AflS). AFB1’s biosynthesis
is also interconnected with developmental genes that play a role in morphology, conidiation, or
sclerotia formation [18,19], as well as genes encoding the velvet regulating proteins that coordinate
primary and secondary metabolism (SM) [20]. Transcription factors (TFs) such as mtfA [21] and
fcr3 (A. nidulans rsmA orthologous) [22] and other TFs influenced by environmental factors like
pH, nitrogen and carbon, can also interfere with aflatoxin production [23]. In the same way, genes
related to oxidative stress regulation [24] as well as genes encoding cellular signal mediators such
as rasA, [25] G-protein receptors [26] and oxylipins’ biosynthetic genes [27] influence toxin synthesis.
This demonstrates the complexity of environmental signals and cellular pathways involved or
interfering with mycotoxin production.
In the present study, a molecular tool was developed including genes directly implicated in
aflatoxin production as well as genes involved in the upstream regulation of this toxin. This tool was
used to determine the molecular mechanism of AFB1’s inhibition by eugenol. Hence, we demonstrate
that this later compound acts at the transcriptomic level to inhibit AFB1 production by restricting the
expression of its biosynthetic cluster. Moreover, we also reveal that this inhibition is mainly governed
by the modification of mtfA and veA’s expression levels.
2. Results
2.1. Effect of Eugenol on Fungal Growth and Aflatoxin B1 Production
Five different concentrations of eugenol were tested for their effect on both fungal development
and AFB1 biosynthesis (Figure 1). Fungal growth was only slightly affected and colony diameter
was reduced by 11.4% for 0.5 mM and 34.5% for 1 mM eugenol. By contrast, eugenol decreased
AFB1 production in a dose-dependent manner with inhibitions of 19.8, 30.9, 70.2 and 100% at eugenol
concentrations of 0.01, 0.05, 0.1 and 0.5–1 mM, respectively.
For subsequent assays, a concentration of 0.5 mM of eugenol was used allowing complete
inhibition of AFB1 production with a limited impact on fungal growth. Since AFB1 production
can be modulated by pH, this parameter was measured in the fungal cultures. Before incubation,
pH values were 5.30 ˘ 0.06 and 5.23 ˘ 0.08 in control and treated cultures, respectively. After four
days at 27 ˝C, both cultures displayed a mild but statistically significant (p-value = 0.049) acidification
with pH means ˘ Standard Error of Mean (SEM) of 4.7 ˘ 0.03 for control and 4.4 ˘ 0.2 for eugenol
treated cultures.
Toxins 2016, 8, 123 3 of 13
Toxins 2016, 8, 123  2 of 13 
 
has  spread  beyond  its  predicted  geographical  borders  and  has  reached  countries  previously 
considered  as  safe.  In  fact,  in  recent  years,  several  surveys  demonstrated  the  contamination  of 
European crops by this toxin [6,7]. Fungal infection can occur at a pre‐ or post‐harvest stage of cereal 
production, especially corn, but also oilseeds, nuts, spices and dried fruit [8]. 
Many strategies have been developed to reduce AFB1 contamination, either by preventing the 
fungal development or by blocking  the  toxin’s production after  infection  [9]. Natural extracts are 
considered as a possible alternative antimicrobial agent [10]. Indeed, organic and aqueous extracts 
from plants and spices, as well as essential oils, have demonstrated fungicidal and/or anti‐toxinogenic 
properties [11–13]. For example, eugenol (4‐allyl‐2‐methoxyphenol), the active compound of many 
anti‐toxinogenic essential oils [14,15], blocks AFB1 production in aflatoxigenic fungi [16,17]. However, 
little is known about the molecular mechanism of this inhibition and the fungal pathways affected 
by eugenol remain to be determined. 
AFB1’s biosynthetic pathway  is well characterized and consists  in A.  flavus, of a cluster of 27 
genes whose expression is governed by two internal regulators (AflR and AflS). AFB1’s biosynthesis 
is  also  interconnected with developmental genes  that play  a  role  in morphology,  conidiation, or 
sclerotia formation [18,19], as well as genes encoding the velvet regulating proteins that coordinate 
primary  and  secondary metabolism  (SM)  [20]. Transcription  factors  (TFs)  such  as mtfA  [21]  and   
fcr3 (A. nidulans rsmA orthologous) [22] and other TFs influenced by environmental factors like pH, 
nitrogen and carbon, can also interfere with aflatoxin production [23]. In the same way, genes related 
to  oxidative  stress  regulation  [24]  as well  as  genes  encoding  cellular  signal mediators  such  as   
rasA, [25] G‐protein receptors [26] and oxylipins’ biosynthetic genes [27] influence toxin synthesis. 
This  demonstrates  the  complexity  of  environmental  signals  and  cellular  pathways  involved  or 
interfering with mycotoxin production. 
In  the present  study, a molecular  tool was developed  including genes directly  implicated  in 
aflatoxin production as well as genes involved in the upstream regulation of this toxin. This tool was 
used to determine the molecular mechanism of AFB1’s inhibition by eugenol. Hence, we demonstrate 
that this later compound acts at the transcriptomic level to inhibit AFB1 production by restricting the 
expression of its biosynthetic cluster. Moreover, we also reveal that this inhibition is mainly governed 
by the modification of mtfA and veA’s expression levels. 
2. Results 
2.1. Effect of Eugenol on Fungal Growth and Aflatoxin B1 Production 
Five different concentrations of eugenol were tested for their effect on both fungal development 
and AFB1 biosynthesis (Figure 1). Fungal growth was only slightly affected and colony diameter was 
reduced by 11.4%  for 0.5 mM and 34.5%  for 1 mM eugenol. By contrast, eugenol decreased AFB1 
production  in a dose‐dependent manner with  inhibitions of 19.8, 30.9, 70.2 and 100% at eugenol 
concentrations of 0.01, 0.05, 0.1 and 0.5–1 mM, respectively. 
 
0
20
40
60
80
100
Control  0.01 0.05 0.1 0.5 1
Pe
rc
en
ta
ge
of
 in
hi
bi
tio
n 
Eugenol concentration (mM) 
AFB1 production 
Fungal growth 
ns
ns ns ns
***
***
*
***
nd nd
Figure 1. Effect of eugenol on Aflatoxin B1 (AFB1) production and fungal growth in A. flavus NRRL
62477. Results are expressed as percentage of the control value. AFB1 was estimated by High
Performance Liquid Chromatography (HPLC) and fungal growth by colony diameter. Both measures
were taken on day 4 on six biological replicates. ns = no significant changes; nd = not detectable;
* p-value < 0.05; *** p-value < 0.001.
2.2. Effect of Eugenol on Aflatoxin Biosynthetic Pathway
In A. flavus, AFB1’s biosynthetic pathway consists of 27 genes regrouped in a cluster where
aflR and aflS are the two internal regulators. Following the addition of 0.5 mM eugenol, AFB1 was
completely inhibited and all cluster genes with the exception of aflT (p-value = 0.8667) were strongly
down-regulated. In fact, the expression of 19 out of 27 genes was almost completely inhibited,
whereas five others had 10- to 20-fold reductions in expression levels compared to control conditions
(Figure 2). Therefore, the extent of down-regulation was mildly different according to the chronological
intervention level of the encoded enzyme in the biosynthetic pathway.
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As an illustration, fundamental genes involved in the first steps of AFB1’s enzymatic cascade,
such as aflC, encoding the polyketide synthase A, and two of fatty acid synthase genes aflA (fas-2) and
aflB (fas-1), appeared less affected by eugenol compared to further intermediate genes such as aflO
(omtB), aflP (omtA) and aflQ (ordA), the latter being an enzyme in charge of the final transformation of
AFB1. For those genes, expression was almost completely inhibited by eugenol (p-values < 0.0001).
The reduced expression of cluster genes went with a decreased expression of the internal
regulators. Concerning aflS, it saw a 3.9-fold down-regulation (p-value = 0.0030) whereas aflR’s
expression level was not significantly affected by eugenol addition (p-value = 0.0522), although a
diminution averaging at half was observed.
2.3. Effect of Eugenol on Regulatory Factors Linked to AFB1 Production
Since AFB1 biosynthesis is strongly interconnected with several other fungal biosynthetic
pathways, a large number of genes considered as regulatory factors were analyzed. They included the
velvet complex, genes involved in oxidative stress response, environmental and global transcription
factors, genes involved in cellular signaling (oxylipins, Ras family and G-protein signaling and
receptors) and developmental regulators (Figure 3).
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As shown in Figure 4, among the 33 tested genes, only seven presented significant modifications
of their level of expression upon eugenol exposure.
These genes were:
‚ The global regulator gene veA, belonging to the velvet complex. It was over-expressed with a
3.8-fold change compared to the control (p-value = 0.002);
‚ mtfA, a putative C2H2 zinc finger transcription factor. It presented the same up-regulated pattern,
increasing its expression by 2.2 times (p-value = 0.0297);
‚ nsdC, of the global transcription factors, whose expression was increased by 1.7 times
(p-value = 0.0100);
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‚ gprK, which was the most affected gene among the five G-protein coupled receptors analyzed
here. This gene was over-expressed by 4.5 times (p-value = 0.0009). By contrast, gprA was
down-regulated by 0.45 times (p-value = 0.0177);
‚ The msnA gene was increased by 1.9 times (p-value < 0.0001), whereas no significant changes
were observed for other genes implicated in the oxidative stress response such as superoxidase
dismutases, catalases or oxylipins;
‚ Finally, pacC’s expression, a zinc finger transcription factor related to pH, was increased by
2.3 times (p-value = 0.0098).
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3. Discussion
A number of natural extracts were identified as being able to down-modulate the synthesis of the
carcinogenic mycotoxin AFB1 in A. flavus [39]. The use of such inhibiting compounds could therefore
represent an alternative strategy to the use of pesticides to control crop contamination. However, to
date, the precise molecular mechanism responsible for this effect is only poorly documented. Indeed,
mycotoxin production is a complex phenomenon based on the presence of biosynthetic clusters in
toxigenic fungi whose regulation is governed by many environmental and physiological processes.
In order to better understand the inhibition of AFB1 production by such natural extracts, we
developed a molecular tool allowing the simultaneous analysis of the expression of both the AFB1
cluster and a large number of global regulatory genes involved in different cellular pathways. We used
it to characterize the mechanism of action of eugenol, a compound present in many essential oils and
that has been previously identified as an AFB1 inhibitor. Eugenol has been extensively studied for
its many biological effects including antimicrobial, anti-inflammatory, anti-oxidant and anticancer
activities. However, to date, no precise cellular target was identified even though the interaction with
cell membrane may represent a key point in the biological effects of this molecule [40].
3.1. Eugenol Inhibits the Expression of Aflatoxin Cluster Genes in A. flavus
The inhibition of AFB1 production by a toxigenic strain of A. flavus following eugenol addition is
accompanied by the down-regulation of all but one aflatoxin cluster genes.
We demonstrated that the expression of 19 out of 27 genes of the cluster was almost no more
detectable after eugenol exposure, whereas the others saw 10- to 20-fold reductions in their expression
levels. These results are coherent with a very recent work of Jahanshiri et al. [16] showing that eugenol
decreased the expression of some of Aflatoxins (AF)’s cluster genes in A. parasiticus. In that previous
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study, only five genes of the pathway were analyzed. Our present work extended this finding to the
whole genes involved in the biosynthesis of AFB1.
AFB1’s cluster is internally regulated by two genes, aflR and aflS, whose activation is governed,
independently one from another, by external regulators. An interaction between AflR and AflS is
reportedly required for aflatoxinogenesis [41]. Kong et al. [42] reported that the activation by these two
proteins led to the formation of a functional activation complex in the proper ratio of four AflS to one
AflR. In our study, the expression of aflR was not significantly decreased in cultures exposed to eugenol,
although a major down-regulation tendency was observed. Such a finding was already described in
several studies where even low-level changes of aflR’s expression levels were accompanied by a severe
decrease of structural genes [25,43,44]. However, levels of aflS transcripts were significantly reduced,
which might have led to an alteration of the ratio between AflR and AflS and thus the formation of
a limited number of active complexes. Consequently, AflR-binding sites were not attained and the
transcription of the cluster was not activated (Figure 2). All of the cluster genes regulated by aflR had
their expression levels severely decreased by eugenol’s addition. The genes intervening in the later
stages of AFB1’s enzymatic cascade (aflM, aflN, aflX, aflO, aflP, aflQ and hypB) were more impacted
than those involved in the beginning stages (aflA, aflB, aflC) leading to the polyketide structure [45].
The limited AflR/AflS complexes formed might have been promptly used up at the beginning of
AFB1’s synthesis and were no longer sufficiently available for the proper activation of the rest of the
cluster genes.
For aflT, the expression levels were not significantly different between control and eugenol-treated
cultures. In fact, aflT, a Major Facilitator Superfamily (MFS) transporter encoding gene, is regulated
neither by AflR nor by its co-activator AflS, due to the absence of an AflR binding-site on its promoter,
but rather by the FadA-dependent G-protein signaling pathway [46]. Moreover, the expression of none
of the genes belonging or affected by the latter pathway, notably fadA, flbA, fluG and brlA [34], has been
altered by eugenol’s addition (Table S1).
3.2. Eugenol Alters the Expression of Global Regulation Factors
Eugenol‘s transcriptomic effect goes upstream of AF’s cluster genes, affecting genes encoding
general transcriptional regulating factors.
3.2.1. The Pivotal Role of MtfA, VeA and MsnA in Eugenol’s Molecular Mechanism
MtfA is a global transcription factor, regulating sterigmatocystin/aflatoxin biosynthesis as well as
other secondary metabolites clusters [31]. The deletion as well as the over-expression of mtfA has been
shown to inhibit the expression of aflR and subsequent sterigmatocystin production in A. nidulans [21].
Also, in the recent work of Zhuang et al. [47] on peanut seeds infected with ∆mtfA and over-expressed
(OE) mtfA gene on A. flavus strains, it was observed that the decrease in AFB1 production was greater
when there was a 2.75-fold mtfA over-expression compared to the wide-type strain, than deleted, and
went with a decreased expression of aflR. Although the mtfA gene is over-expressed at a similar level as
in the above-quoted study [47], this does not mean that MtfA is the direct molecular target of eugenol.
A kinetic study of gene expression, using our molecular tool coupled to AF production analysis, could
be used in order to determine the time course evolution of modulated genes.
Furthermore, mtfA’s expression is highly dependent on that of veA. As discussed in the study
by Lind et al. [31], MtfA interacts with VeA in A. nidulans and the expression of mtfA (AN8741.2) was
decreased by 5 times in an A. nidulans ∆veA. All of the above findings are in favor of the notion that the
over-expression of mtfA in A. flavus is a result of the increased expression of veA upon eugenol addition.
The interaction of these two regulators could then be responsible for aflR’s down-regulation and the
succeeding inhibition of AF’s biosynthetic pathway in A. flavus. Moreover, VeA is by itself essential for
the transcription of both aflR and aflS and, consequently, the production of aflatoxins [48]. This global
transcription regulator plays a key role in secondary metabolite production [49]. Depending on its
abundance in the cell, it may act as a repressor or as an activator [50]. For instance, the expression
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of fumagillin and fumitremorgin G gene clusters was inhibited in a overexpressing veA (OE:veA)
strain of A. fumigatus [51]. Therefore, an over-expression of veA (3.8-fold) observed here is compatible
with the down-regulation of aflR and aflS and the subsequent inhibition of aflatoxin production in
eugenol-treated cultures. Furthermore, as in many filamentous fungi, SM, and aflatoxin production
in particular are often induced as a response to Reactive Oxygen Species (ROS) formation [52]. It has
been also demonstrated that VeA plays a critical role in protecting A. flavus from oxidative stress.
VeA positively regulates the expression of oxidative stress tolerance genes such as msnA in A. flavus [38]
and also in A. nidulans [31]. Conversely, levels of ROS as well as AFB1 increased in ∆msnA A. flavus
and A. parasiticus strains [53]. Furthermore, it has been demonstrated that aflatoxin biosynthesis is
itself a source of intracellular ROS, and the over-expression of msnA could then also be the outcome of
AFB1’s inhibition [54].
Accordingly, an oxidative-stress alleviating condition, such as the addition of eugenol, could lead
to an increased expression of veA and consequently of msnA. In our study, msnA transcripts increased
by 1.9 times along with AFB1’s inhibition in eugenol-treated cultures, following veA’s over-expression.
This effect is possibly linked to a decrease of intracellular ROS.
3.2.2. The Putative Implication of Other Regulatory Factors and Signaling Proteins
Eugenol addition also alters the expression of other transcription-regulating factors such as
(i) nsdC and (ii) pacC encoding a pH-dependent transcription factor, as well as (iii) the grpA and grpK
genes involved in the G-protein signaling pathway. Except for grpK, these genes have been shown to
be closely related to the expression of AF cluster genes and AFB1 production [19,26,55,56]. However,
to date, the exact mechanism of this interaction has to be clarified.
4. Conclusions
In this study, we bring out the transcriptomic inhibition behind eugenol’s AFB1-repressing
action. This is the first time, to our knowledge, that the expression of all the 27 genes involved
in AFB1 synthesis has been studied on an inhibitor molecule. In the presence of eugenol, AFB1
cluster genes were strongly down-modulated following decreased expression of its regulating complex
AflR/AflS. We also demonstrated that this went with a modulation of seven regulatory factors. We then
highlighted the involvement of mtfA, veA and msnA in this inhibition.
5. Materials and Methods
5.1. Chemicals and Reagents
Aflatoxin B1 and eugenol standards were purchased from Sigma-Aldrich (Saint-Quentin-Fallavier,
France) and dissolved in methanol and ethanol, respectively. Stock solutions were stored at 4 ˝C until
use. All analytical grade solvents were purchased from Thermo Fisher Scientific (Illkirch, France).
5.2. Fungal Strain and Culture Conditions
The Aspergillus flavus strain NRRL 62477 used in this study [57] was maintened in the dark on a
Malt Extract Agar (MEA) medium (Biokar Diagnostics, Allone, France) at 27 ˝C.
For experiments, 10 µL of a calibrated spore suspension (106 spores/mL) prepared from a
seven-day culture was used to centrally inoculate the MEA medium covered with sterile cellophane
layers (Hutchinson, Chalette-sur-Loing, France) as described by Leite et al. [58]. Firstly, five different
concentrations of eugenol (0.1 to 1 mM) were tested to determine the concentration able to inhibit AFB1
with a limited impact on fungal development, as measured by colony diameter. The concentration of
0.5 mM was selected for further experiments. Eugenol dilutions were prepared to add only 20 µL of
ethanol in the culture medium, this concentration having been identified as a no-effect dose on both
fungal growth and AFB1 production. Control cultures were performed by adding only 20 µL of ethanol
in the medium. Six replicates of each group were prepared and incubated for four days at 27 ˝C in the
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dark. At least three replications of the experiment were performed. The pH of all media was taken
before and after incubation using a food pH-meter H199161 (Hanna Instruments, Tanneries, France).
5.3. Aflatoxin B1 Extraction and Determination by HPLC
For AFB1 extraction, culture media were mixed with 25 mL of chloroform. Samples were agitated
for 2 h on a horizontal shaking table at 160 rpm at room temperature. Chloroform extract was filtered
through a Whatman 1PS phase separator (GE Healthcare Life Sciences, Vélizy-Villacoublay, France),
evaporated at 60 ˝C until dry and dissolved in 500 µL of a water-acetonitrile-methanol (65:17.5:17.5;
v/v/v) mixture. To eliminate possible impurities, all samples were filtered through a 0.45 µm disk
filters (Thermo Scientific Fisher, Villebon-Sur-Yvette, France). The analysis of samples was done
with a Dionex Ultimate 3000 UHPLC system (Thermo Scientific, Illkirch, France) using a liquid
chromatography column, Luna® C18 (125 ˆ 2 mm, 5 µm, 100 Å) (Phenomenex, Torrance, CA, USA)
at 30 ˝C. Separation conditions were adapted from Fu et al. [59] with mild modifications. A 20 min
isocratic mode was delivered at 82.5% of eluent A: acidified water (0.2% of acetic acid) and acetonitrile
(79:21 v/v); and 17.5% of eluent B: pure methanol. A flow rate of 0.2 mL/min was used and 10 µL of
extract was injected. AFB1 was detected by a fluorescent detector at 365/430 nm excitation/emission
wavelengths. Peak identity was confirmed by analyzing absorption spectrum with a diode array
detector coupled to the system. Production levels of AFB1 on media were calculated based on a
standard calibration curve.
5.4. Isolation of Fungal RNA and Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)
At the end of incubation, mycelia were separated from the medium and ground up under liquid
nitrogen. The RNA was purified as recommended by the manufacturer from 100 mg of mycelium
using a Qiagen RNeasy PlusMinikit (Qiagen, Hilden, Germany) and including a gDNA eliminator
column. The quality of RNA was verified by gel electrophoresis (1.2% agarose) and concentrations
were measured using a NanoDrop ND1000 (Labtech, Palaiseau, France). The A260/A280 ratio was
measured [60], and each sample was adjusted to a final RNA concentration of 300 ng/µL.
First-strand cDNA synthesis was carried out by RT-PCR. Reverse transcription took place in a
20 µL reaction mixture containing 10 µL of RNA, 200 U of RevertAid Reverse transcriptase, 4 µL of
5ˆ Reaction Buffer, 20 U of RNase inhibitor (Thermo Scientific, Illkirch, France), 2 µL of 10 mM dNTP
(Euromedex, Souffelweyersheim, France), 1 µL of sterile water, and 1 µL of oligo (dT) Bys 3' Primer:
(5'-GCTGTCAACGATACGCTATAACGGCATGACAGTGTTTTTTTTTTTTTTT-3').
A first denaturation was done at 70 ˝C for 5 min and reverse transcription was performed as
follows: 5 min at 37 ˝C; 60 min at 42 ˝C and 15 min at 85 ˝C.
5.5. Design and Validation of q-PCR Primers
All primer sets were designed based on the genomic data of the Aspergillus flavus strain NRRL3357
(GenBank accession number EQ963478A). A total of 62 genes primer pairs were designed including
all 27 AFB1 cluster genes. It must be noted that aflF and aflU were not followed in this study, as the
promoter regions of both genes are missing in A. flavus species, thus their inability to produce type-G
aflatoxins. Other regulatory factors directly or indirectly related to AFB1’s production (Figure 3) were
included, along with two housekeeping genes, b-tubulin and gpdA. All primer pairs were designed to
amplify a 50–150 bp fragment based solely on the coding sequence of the corresponding genes, with at
least one of the primers extending on an exon/exon junction in order to avoid undesirable genomic
DNA amplification. Primer-dimer or self-complementarities were evaluated using the PrimerExpress
2.0 software (Applied Biosystems, Courtaboeuf, France). All primers were synthesized by Sigma
Aldrich (Saint-Quentin Fallavier, France) and tested with four different concentrations (300/300;
300/900; 900/300 and 900/900 nM) after reception to determine their optimal concentrations in the
mix. Primer validation was carried out with the best amplification curve and dissociation curves
were used to confirm the good amplification of each gene. At least three biological replicates of
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A. flavus NRRL62477 were used to validate the amplification specificity. Negative controls in which no
reverse transcriptase enzyme was added and a no template control were included to control reagents
contamination. Primer sequences and their concentrations are listed in Table S2.
5.6. Analysis of the Expression of the Genes Linked to Aflatoxin B1 Biosynthesis
Experiments were carried out using a ViiA7 Real-Time PCR System (Applied Biosystems,
Forster City, CA, USA). The 384 well-plates were prepared by an Agilent Bravo Automated Liquid
Handling Platform (Agilent Technologies, Santa Clara, CA, USA). Each well contained a final volume
of a 5 µL mix: 2.5 µL of Power SYBR® Green PCR Master Mix (Applied Biosystems, Warrington, UK)
used as a fluorescent dye, 1.5 µL of each primer set and 1 µL of cDNA material. Three-step quantitative
PCRs were performed as follows: a first one-hold stage at 95 ˝C for 10 min followed by 45 cycles (95 ˝C
for 15 s and 60 ˝C for 30 s), and a final extending step (95 ˝C for 15 s, 60 ˝C for 1 min and 95 ˝C for 15 s)
for melt curve analysis. The results were analyzed with a Quant-Studio Real time PCR software v1.1
(Applied Biosystems, Courtaboeuf, France). Housekeeping genes were analyzed with Normfinder
algorithm [61] and the more stable was used as a reference for normalization in the 2´∆∆Ct analysis
method [62]. Five distinct experiments were done, each including at least three biological replicates of
each condition.
5.7. Statistics
Student’s t-test was used to analyze the differences between control and treated samples.
The differences were considered to be statistically significant when the p-value was lower than 0.05.
Supplementary Materials: The following are available online at www.mdpi.com/2072-6651/8/5/123/s1,
Table S1: Gene expression values of regulatory factors that were not impacted upon Eugenol addition. Values are
expressed in fold change and compared to a control fixed at 1; Table S2: Primer sequences of the 62 designed genes.
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